FDA Keeps Brand-Name Drugs On A Fast Path To Market ― Despite Manufacturing Concerns
The agency approved Gilead’s “game changer” hepatitis C cure, bypassing concerns raised by its own federal inspectors. The problems they found at the company’s main U.S. drug-testing laboratory in Foster City, Calif., were so bad, they recommended withholding approval.
Grief Grew Into A Mental Health Crisis And A $21,634 Hospital Bill
She spent five days in the hospital undergoing psychiatric care. The bill she got is about the same price as a new Honda Civic.
Pharma Sells States On ‘Netflix Model’ To Wipe Out Hep C. But At What Price?
Manufacturers of lucrative drugs say they’re offering discounts off the high sticker prices ― but taxpayers footing the big bills might never know what the state is paying or if it’s getting a good deal.
A Million-Dollar Marketing Juggernaut Pushes 3D Mammograms
Companies are aggressively touting 3D mammograms, although there’s no evidence they save lives.
‘Fear Of Falling’: How Hospitals Do Even More Harm By Keeping Patients In Bed
In what experts call an “epidemic of immobility,” older hospital patients remain stuck in bed, their movements tracked by loud and ineffective bed alarms, losing muscle mass that’s key to their health and daily functioning.
Cosmetic Surgery And The Secret World of Instagram Dolls
An Instagram community of “doll pages” lets women find valuable information about body-sculpting journeys.
Investors’ Deep-Pocket Push To Defend Surprise Medical Bills
As lobbyists purporting to represent doctors and hospitals fight attempts to control surprise medical bills, it has become increasingly clear that the force behind the effort is not just medical professionals, but also investors from private equity firms.
Mysterious Vaping Lung Injuries May Have Flown Under Regulatory Radar
Doctors who saw patients with a mysterious lung illness in the past suspected vaping as the cause but didn’t know where to report such cases. “It wasn’t that I didn’t want to report it, it’s that there’s no pathway,” said one California pulmonologist.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Addiction Clinics Market Pricey, Unproven Treatments To Desperate Patients
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.